Hormone treatment to improve IVF trigger and FET support
Part of Women’s health & pregnancy clinical trials.
This study tests whether a specific hormone plan can improve outcomes in two parts of fertility treatment: IVF timing (the “trigger”) and hormone support during frozen embryo transfer (FET). It may help some people have better chances for successful embryo implantation and pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under age 43 when you start IVF treatment
- You are having either IVF, or a natural-cycle frozen embryo transfer (FET)
- You use your own eggs and embryos (not donor eggs/embryos)
- No preimplantation genetic testing is planned for your embryos
- You do not have an untreated hydrosalpinx (an abnormal, fluid-filled fallopian tube)
- You are not considered at high risk for OHSS (a serious ovarian swelling condition)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether taking an oral progesterone-like medicine (dydrogesterone) during the “luteal phase” after a natural-cycle frozen embryo transfer can improve support for implantation. It may help couples who are using their own embryos in a natural (hormone-sparing) cycle after thawing.
This study tests different medication approaches to help women who had a low number of eggs in a previous IVF cycle produce more eggs this time. The goal is to find a better stimulation method for women with this 'low response' pattern.
This trial tests whether giving a medication called a GnRH agonist (which affects hormones) before a frozen embryo transfer can improve the chances of pregnancy in women with infertility. It aims to see if this treatment helps the uterus accept the embryo better.
This trial studies whether giving a GnRH “downshifting” shot before transferring a frozen embryo can improve pregnancy outcomes for people with endometriosis or adenomyosis. It may help by changing hormone activity before the transfer.
This trial tests whether giving a medication called a GnRH agonist during the luteal phase (the time after egg retrieval) can help with IVF success. It is for people who are using a specific medication protocol (recombinant FSH with an antagonist) and have certain hormone levels.
This trial tests whether a hormone called GnRH can help support the lining of the uterus after IVF, ICSI, or frozen embryo (FET) embryo transfer. It may be offered around the time of embryo transfer to improve the chances of a successful implantation.
Hear when a new Subfertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.